Your browser doesn't support javascript.
loading
Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.
Niquet, Jerome; Baldwin, Roger; Norman, Keith; Suchomelova, Lucie; Lumley, Lucille; Wasterlain, Claude G.
Affiliation
  • Niquet J; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
  • Baldwin R; Epilepsy Research Laboratory (151), Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, U.S.A.
  • Norman K; Epilepsy Research Laboratory (151), Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, U.S.A.
  • Suchomelova L; Epilepsy Research Laboratory (151), Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, U.S.A.
  • Lumley L; Epilepsy Research Laboratory (151), Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, U.S.A.
  • Wasterlain CG; US Army Medical Research Institute of Chemical Defense (USAMRICD), Aberdeen Proving Ground, Maryland, U.S.A.
Epilepsia ; 57(9): 1406-15, 2016 09.
Article in En | MEDLINE | ID: mdl-27500978

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Hidroterapia Main subject: Status Epilepticus / Midazolam / Maze Learning / Cholinergic Agents / Ketamine / Learning Disabilities / Anticonvulsants Type of study: Etiology_studies Language: En Journal: Epilepsia Year: 2016 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Hidroterapia Main subject: Status Epilepticus / Midazolam / Maze Learning / Cholinergic Agents / Ketamine / Learning Disabilities / Anticonvulsants Type of study: Etiology_studies Language: En Journal: Epilepsia Year: 2016 Type: Article Affiliation country: United States